You are here

Clearside Biomedical

Clearside’s long-acting eye project shows promise

EP Vantage

Wed, 06/16/21 - 11:48 am

Clearside Biomedical

wet age-related macular degeneration

The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings

Yahoo/Benzinga

Mon, 10/14/19 - 09:43 am

Flexion Therapeutics

Clearside Biomedical

Assertio Therapeutics

Aldeyra Therapeutics

Lineage Therapeutics

Clearside Biomedical predicts its uveitis drug will be rejected, after FDA requests more data

Endpoints

Sat, 08/24/19 - 11:08 am

Clearside Biomedical

Clearside Biomedical shares soar after eye drug succeeds in Ph3 trial

Drug Delivery Business News

Mon, 03/5/18 - 09:32 am

Clearside Biomedical

clinical trials

non-infectious uveitis

Clearside enrolls first patient in phase III trial of Zuprata combination therapy

Drug Delivery Business News

Mon, 02/20/17 - 09:53 am

Clearside Biomedical

retinal vein occulsion

5 Biotech IPOs Lead The Way In 2016

Seeking Alpha

Mon, 11/28/16 - 09:51 am

Clearside Biomedical

Protagonist Therapeutics

Reata Pharmaceuticals